409 related articles for article (PubMed ID: 22970722)
1. Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges.
Desnick RJ; Schuchman EH
Annu Rev Genomics Hum Genet; 2012; 13():307-35. PubMed ID: 22970722
[TBL] [Abstract][Full Text] [Related]
2. Enzyme replacement therapy for lysosomal storage diseases.
Lachmann RH
Curr Opin Pediatr; 2011 Dec; 23(6):588-93. PubMed ID: 21946346
[TBL] [Abstract][Full Text] [Related]
3. Enzyme replacement therapy for lysosomal storage diseases.
Ohashi T
Pediatr Endocrinol Rev; 2012 Oct; 10 Suppl 1():26-34. PubMed ID: 23330243
[TBL] [Abstract][Full Text] [Related]
4. Enzyme replacement and enhancement therapies for lysosomal diseases.
Desnick RJ
J Inherit Metab Dis; 2004; 27(3):385-410. PubMed ID: 15190196
[TBL] [Abstract][Full Text] [Related]
5. Treatments for lysosomal storage disorders.
Lachmann R
Biochem Soc Trans; 2010 Dec; 38(6):1465-8. PubMed ID: 21118108
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for the lysosomal storage disorders.
Cabrera-Salazar MA; Novelli E; Barranger JA
Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873
[TBL] [Abstract][Full Text] [Related]
7. Oral small molecule therapy for lysosomal storage diseases.
Weinreb NJ
Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():77-90. PubMed ID: 24380126
[TBL] [Abstract][Full Text] [Related]
8. Treatment of lysosomal storage disorders : progress with enzyme replacement therapy.
Rohrbach M; Clarke JT
Drugs; 2007; 67(18):2697-716. PubMed ID: 18062719
[TBL] [Abstract][Full Text] [Related]
9. Treatment of lysosomal storage diseases: recent patents and future strategies.
Ortolano S; Viéitez I; Navarro C; Spuch C
Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):9-25. PubMed ID: 24433521
[TBL] [Abstract][Full Text] [Related]
10. [Lysosomes and lysosomal storage diseases].
Germain DP
J Soc Biol; 2002; 196(2):127-34. PubMed ID: 12360741
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary involvement in selected lysosomal storage diseases and the impact of enzyme replacement therapy: A state-of-the art review.
Jezela-Stanek A; Chorostowska-Wynimko J; Tylki-Szymańska A
Clin Respir J; 2020 May; 14(5):422-429. PubMed ID: 31912638
[TBL] [Abstract][Full Text] [Related]
12. Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders.
Coutinho MF; Santos JI; Alves S
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27384562
[TBL] [Abstract][Full Text] [Related]
13. Immune response to enzyme replacement therapy in lysosomal storage disorder patients and animal models.
Brooks DA
Mol Genet Metab; 1999 Oct; 68(2):268-75. PubMed ID: 10527678
[TBL] [Abstract][Full Text] [Related]
14. Enzyme Replacement Therapy: A Review and Its Role in Treating Lysosomal Storage Diseases.
Li M
Pediatr Ann; 2018 May; 47(5):e191-e197. PubMed ID: 29750286
[TBL] [Abstract][Full Text] [Related]
15. Targeting macrophages with baculovirus-produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis.
Bonten EJ; Wang D; Toy JN; Mann L; Mignardot A; Yogalingam G; D'Azzo A
FASEB J; 2004 Jun; 18(9):971-3. PubMed ID: 15084520
[TBL] [Abstract][Full Text] [Related]
16. Treating lysosomal storage disorders: What have we learnt?
Lachmann RH
J Inherit Metab Dis; 2020 Jan; 43(1):125-132. PubMed ID: 31140601
[TBL] [Abstract][Full Text] [Related]
17. Treatment for LSDs: no longer just enzyme replacement therapy for Gaucher disease. Foreword.
Cohen IJ; Baris H; Mistry PK
Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():58. PubMed ID: 24380122
[No Abstract] [Full Text] [Related]
18. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective.
Thomas R; Kermode AR
Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228
[TBL] [Abstract][Full Text] [Related]
19. Therapy for lysosomal storage disorders.
Beck M
IUBMB Life; 2010 Jan; 62(1):33-40. PubMed ID: 20014233
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for lysosomal storage disorders: developing insights.
van Gelder CM; Vollebregt AA; Plug I; van der Ploeg AT; Reuser AJ
Expert Opin Pharmacother; 2012 Nov; 13(16):2281-99. PubMed ID: 23009070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
